⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL31423957 | 1.00 | — | — | |
| SCHEMBL31423982 | 1.00 | — | — | |
| SCHEMBL31423991 | 1.00 | — | — | |
| SCHEMBL31423935 | 1.00 | — | — | |
| SCHEMBL31458628 | 0.90 | PRKDC (0.30) | — | |
| SCHEMBL31423941 | 0.82 | MAPK8 (0.38) | — | |
| SCHEMBL31423945 | 0.82 | MAPK8 (0.38) | — | |
| SCHEMBL31424004 | 0.81 | JAK2 (0.35) | — | |
| SCHEMBL31423888 | 0.80 | — | — | |
| SCHEMBL31423900 | 0.80 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2025054386-A1 | CDK2 INHIBITORS AND USES THEREOF | ODYSSEY THERAPEUTICS, INC. (US) | 2025-03-13 | — | — | WO | disclosed |